Arphra
live
S&P 5007,512.99-0.55%
NASDAQ29,968.13-1.89%
DOW51,999.67+0.64%
VIX16.41+1.30%
US10Y4.43-0.92%
EUR/USD1.1615+0.20%
GOLD4,355.5+0.47%
WTI75.90-6.78%
BTC65,667.9-0.74%
S&P 5007,512.99-0.55%
NASDAQ29,968.13-1.89%
DOW51,999.67+0.64%
VIX16.41+1.30%
US10Y4.43-0.92%
EUR/USD1.1615+0.20%
GOLD4,355.5+0.47%
WTI75.90-6.78%
BTC65,667.9-0.74%

CNVIF

Conavi Medical Corp.
HealthcareMedical - DevicesCAUSDPeers →via fmp_bulkCountry macro →
$0.18
LiveJun 16, 2026
AI Brief
Market cap
$15.3M
52w range
0.15 – 0.56
P / E
EPS
Volume
85
Revenue · FY

Explain this page

Arphra AI
Business description
· company · SEC profile

Conavi Medical Corp.

Conavi Medical Corp. is a medical technology firm that specializes in developing, manufacturing, and commercializing advanced imaging solutions. These innovations are specifically designed to provide guidance during minimally invasive cardiovascular procedures. A notable product is the Novasight Hybrid System, which uniquely combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. This enables clinicians to obtain simultaneous and precisely co-registered images of the coronary arteries. Conavi Medical Corp. is headquartered in Toronto, Canada.

Founded
IPO
Oct 14, 2024
Employees
4
HQ
Toronto, ON
CEO
Thomas Looby
CFO
Exchange
OTC
Fiscal year
Identifiers
· company_identifiers
CIK0000840551
CUSIP205953102
ISINCA2059531020
FIGI
LEI